Literature DB >> 12521216

Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura.

Nozomu Kamei1, Kiminori Yamane, Yasuyo Yamashita, Shuhei Nakanishi, Hiroshi Watanabe, Rumi Fujikawa, Keiko Hiyama, Shinichi Ishioka, Ciro Mendoza, Nobuoki Kohno.   

Abstract

Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose gamma-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12521216     DOI: 10.2169/internalmedicine.41.1199

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction.

Authors:  Tadashi Nakamura; Syu-ichi Higashi; Kunihiko Tomoda; Michishi Tsukano; Kazuhiro Sugi
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

2.  Association between XRCC3 Thr241Met SNP and systemic lupus erythematosus in Han Chinese patients in Taiwan, and a meta-analysis of healthy populations.

Authors:  Yng-Tay Chen; Shih-Yin Chen; Ying-Ju Lin; Chung-Ming Huang; Yuan-Yen Chang; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

3.  Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.

Authors:  Mengle Peng; Xueliang Zhou; Xianfei Ding; Liqiang Wei; Yong Zhao; Tao Zhu; Xiaoqing Shi; Dongchun Qin
Journal:  Rheumatol Int       Date:  2016-11-03       Impact factor: 2.631

Review 4.  Inflammatory myopathies overlapping with systemic sclerosis: a systematic review.

Authors:  Jucier Gonçalves Júnior; Naoki Mugii; Pleiades Tiharu Inaoka; Percival Degrava Sampaio-Barros; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2022-02-27       Impact factor: 2.980

5.  Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Authors:  S Hoa; M Hudson; Y Troyanov; S Proudman; J Walker; W Stevens; M Nikpour; S Assassi; M D Mayes; M Wang; M Baron; M J Fritzler
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.